AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2016

Mar 14, 2016

32870_dirs_2016-03-14_30dc03d7-0f7e-4978-a835-0e914820902a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2016-03-11

Reporting Person: SULLIVAN LOUIS W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-11	Common Stock	M	14879	$10.28	Acquired	43379	Direct
2016-03-11	Common Stock	S	14879	$34.03	Disposed	28500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-11	Stock Option	$10.28	M	14879	Disposed	2016-06-29	Common Stock (14879)	Direct

Footnotes

F1: Consists of an option granted under the company's stock incentive plan on June 30, 2006.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.36, inclusive.

F3: The option vested in three equal installments in June 2007, 2008 and 2009.